Publications

• Combating yellow fever virus with 7-deaza-7-fluoro-2'-C-methyladenosine.
  Antimicrob Agents Chemother Volume: 69 Page(s): e0188924
  05/07/2025 Authors: LeCher JC; Costa VV; Rust LN; Bassit LC; Patel D; Rezaei S; Moua J; Santos FRDS; Goncalves MR; Queroz-Junior CM
• A Phase 1 randomized trial of homologous and heterologous filovirus vaccines with a late booster dose.
  NPJ Vaccines Volume: 9 Page(s): 255
  12/23/2024 Authors: Rostad CA; Yildirim I; Kao C; Yi J; Kamidani S; Peters E; Stephens K; Gibson T; Hsiao H-M; Singh K
• Rhinoviruses A and C elicit long-lasting antibody responses with limited cross-neutralization.
  J Med Virol Volume: 95 Page(s): e29058
  08/01/2023 Authors: Bochkov YA; Devries M; Tetreault K; Gangnon R; Lee S; Bacharier LB; Busse WW; Camargo CA; Choi T; Cohen R
• Discovery of a 2'-Fluoro,2'-Bromouridine Phosphoramidate Prodrug Exhibiting Anti-Yellow Fever Virus Activity in Culture and in Mice.
  Microorganisms Volume: 10
  10/22/2022 Authors: LeCher JC; Zandi K; Costa VV; Amblard F; Tao S; Patel D; Lee S; da Silva Santos FR; Goncalves MR; Queroz-Junior CM
• Relationship between blood type and outcomes following COVID-19 infection.
  Semin Vasc Surg Volume: 34 Page(s): 125 - 131
  09/01/2021 Authors: Kim Y; Latz CA; DeCarlo CS; Lee S; Png CYM; Kibrik P; Sung E; Alabi O; Dua A
• A Respiratory Syncytial Virus Attachment Gene Variant Associated with More Severe Disease in Infants Decreases Fusion Protein Expression, Which May Facilitate Immune Evasion.
  J Virol Volume: 95
  12/22/2020 Authors: Human S; Hotard AL; Rostad CA; Lee S; McCormick L; Larkin EK; Peret TCT; Jorba J; Lanzone J; Gebretsadik T
• Antigenicity and immunogenicity of unique prefusion-mimic F proteins presented on enveloped virus-like particles.
  Vaccine Volume: 37 Page(s): 6656 - 6664
  10/16/2019 Authors: Kwon Y-M; Lee Y; Kim KH; Jung YJ; Li Z; Jeeva S; Lee S; Moore ML; Kang S-M
• The association of comorbid depression with mortality and amputation in veterans with peripheral artery disease.
  J Vasc Surg Volume: 68 Page(s): 536 - 545.e2
  08/01/2018 Authors: Arya S; Lee S; Zahner GJ; Cohen BE; Hiramoto J; Wolkowitz OM; Khakharia A; Binney ZO; Grenon SM
• Orally Efficacious Broad-Spectrum Ribonucleoside Analog Inhibitor of Influenza and Respiratory Syncytial Viruses.
  Antimicrob Agents Chemother Volume: 62
  08/01/2018 Authors: Yoon J-J; Toots M; Lee S; Lee M-E; Ludeke B; Luczo JM; Ganti K; Cox RM; Sticher ZM; Edpuganti V
• Generating Neutralizing Antibody responses using Recombinant Infectious Rhinovirus
  Volume: 200
  05/01/2018 Authors: Lee S; Tang R; Currier M; Moore M
• Enhancing the Thermostability and Immunogenicity of a Respiratory Syncytial Virus (RSV) Live-Attenuated Vaccine by Incorporating Unique RSV Line19F Protein Residues.
  J Virol Volume: 92
  03/15/2018 Authors: Rostad CA; Stobart CC; Todd SO; Molina SA; Lee S; Blanco JCG; Moore ML
• Immunogenicity of 50-Valent Rhinovirus Vaccine
  Volume: 139 Page(s): AB376 - AB376
  02/01/2017 Authors: Lee S; Nguyen MT; Currier MG; Jenkins JB; Strobert EA; Kajon AE; Madan-Lala R; Bochkov YA; Gern JE; Roy K
• Optimization of Peptide Vaccines to Induce Robust Antitumor CD4 T-cell Responses.
  Cancer Immunol Res Volume: 5 Page(s): 72 - 83
  01/01/2017 Authors: Kumai T; Lee S; Cho H-I; Sultan H; Kobayashi H; Harabuchi Y; Celis E
• A live RSV vaccine with engineered thermostability is immunogenic in cotton rats despite high attenuation.
  Nat Commun Volume: 7 Page(s): 13916
  12/21/2016 Authors: Stobart CC; Rostad CA; Ke Z; Dillard RS; Hampton CM; Strauss JD; Yi H; Hotard AL; Meng J; Pickles RJ
• A polyvalent inactivated rhinovirus vaccine is broadly immunogenic in rhesus macaques.
  Nat Commun Volume: 7 Page(s): 12838
  09/22/2016 Authors: Lee S; Nguyen MT; Currier MG; Jenkins JB; Strobert EA; Kajon AE; Madan-Lala R; Bochkov YA; Gern JE; Roy K
• EGFR Interacts with the Fusion Protein of Respiratory Syncytial Virus Strain 2-20 and Mediates Infection and Mucin Expression.
  PLoS Pathog Volume: 12 Page(s): e1005622
  05/01/2016 Authors: Currier MG; Lee S; Stobart CC; Hotard AL; Villenave R; Meng J; Pretto CD; Shields MD; Nguyen MT; Todd SO
• Respiratory Syncytial Virus Attachment Glycoprotein Contribution to Infection Depends on the Specific Fusion Protein.
  J Virol Volume: 90 Page(s): 245 - 253
  01/01/2016 Authors: Meng J; Hotard AL; Currier MG; Lee S; Stobart CC; Moore ML
• Recent advances of vaccine adjuvants for infectious diseases.
  Immune Netw Volume: 15 Page(s): 51 - 57
  04/01/2015 Authors: Lee S; Nguyen MT
• Virus-like nanoparticle and DNA vaccination confers protection against respiratory syncytial virus by modulating innate and adaptive immune cells.
  Nanomedicine Volume: 11 Page(s): 99 - 108
  01/01/2015 Authors: Ko E-J; Kwon Y-M; Lee JS; Hwang HS; Yoo S-E; Lee Y-N; Lee Y-T; Kim M-C; Cho MK; Lee YR
• Identification of residues in the human respiratory syncytial virus fusion protein that modulate fusion activity and pathogenesis.
  J Virol Volume: 89 Page(s): 512 - 522
  01/01/2015 Authors: Hotard AL; Lee S; Currier MG; Crowe JE; Sakamoto K; Newcomb DC; Peebles RS; Plemper RK; Moore ML
• Additive protection induced by mixed virus-like particles presenting respiratory syncytial virus fusion or attachment glycoproteins.
  Antiviral Res Volume: 111 Page(s): 129 - 135
  11/01/2014 Authors: Lee S; Quan F-S; Kwon Y; Sakamoto K; Kang S-M; Compans RW; Moore ML
• Refining the balance of attenuation and immunogenicity of respiratory syncytial virus by targeted codon deoptimization of virulence genes.
  mBio Volume: 5 Page(s): e01704 - e01714
  09/23/2014 Authors: Meng J; Lee S; Hotard AL; Moore ML
• Cross-resistance mechanism of respiratory syncytial virus against structurally diverse entry inhibitors.
  Proc Natl Acad Sci U S A Volume: 111 Page(s): E3441 - E3449
  08/19/2014 Authors: Yan D; Lee S; Thakkar VD; Luo M; Moore ML; Plemper RK
• Maternal antibodies by passive immunization with formalin inactivated respiratory syncytial virus confer protection without vaccine-enhanced disease.
  Antiviral Res Volume: 104 Page(s): 1 - 6
  04/01/2014 Authors: Kwon Y-M; Hwang HS; Lee JS; Ko E-J; Yoo S-E; Kim M-C; Lee Y-N; Kim K-H; Song J-M; Lee S
• Epidermal Growth Factor Receptor (EGFR) Mediates Cell Fusion and Infectivity Of Respiratory Syncytial Virus (RSV)
  Volume: 133 Page(s): AB71 - AB71
  02/01/2014 Authors: Lee S; Currier MG; Hotard AL; Meng J; Pretto C; Power UF; Villenave R; Shields MD; Chi MH; Peebles RS
• Targeting CD137 enhances vaccine-elicited anti-respiratory syncytial virus CD8+ T cell responses in aged mice.
  J Immunol Volume: 192 Page(s): 293 - 299
  01/01/2014 Authors: Lee S; Mittler RS; Moore ML
• The respiratory syncytial virus fusion protein and neutrophils mediate the airway mucin response to pathogenic respiratory syncytial virus infection.
  J Virol Volume: 87 Page(s): 10070 - 10082
  09/01/2013 Authors: Stokes KL; Currier MG; Sakamoto K; Lee S; Collins PL; Plemper RK; Moore ML
• Analysis of bronchoalveolar immune cells and cytokines induced by immunization with different respiratory syncytial virus vaccines
  Volume: 190
  05/01/2013 Authors: Ko E-J; Lee JS; Lee Y-N; Kwon Y-M; Hwang HS; Yoo S-E; Quan F-S; Lee S; Moore M; Kang S-M
• Enhancement of vaccine-induced respiratory syncytial virus-specific memory CD8 T cell responses by targeting 41BB
  Volume: 190
  05/01/2013 Authors: Lee S; Moore M
• A stabilized respiratory syncytial virus reverse genetics system amenable to recombination-mediated mutagenesis.
  Virology Volume: 434 Page(s): 129 - 136
  12/05/2012 Authors: Hotard AL; Shaikh FY; Lee S; Yan D; Teng MN; Plemper RK; Crowe JE; Moore ML
• Vaccine-elicited CD8+ T cells protect against respiratory syncytial virus strain A2-line19F-induced pathogenesis in BALB/c mice.
  J Virol Volume: 86 Page(s): 13016 - 13024
  12/01/2012 Authors: Lee S; Stokes KL; Currier MG; Sakamoto K; Lukacs NW; Celis E; Moore ML
• An adjuvanted respiratory syncytial virus fusion protein induces protection in aged BALB/c mice.
  Immun Ageing Volume: 9 Page(s): 21
  10/02/2012 Authors: Cherukuri A; Stokes KL; Patton K; Kuo H; Sakamoto K; Lambert S; Stillman E; Moore ML; Lee S
• Vaccine-elicited CD8+T cells protect against respiratory syncytial virus-induced lung airway obstruction
  Volume: 188
  05/01/2012 Authors: Lee S; Stokes K; Celis E; Moore M
• Viruslike particle vaccine induces protection against respiratory syncytial virus infection in mice.
  J Infect Dis Volume: 204 Page(s): 987 - 995
  10/01/2011 Authors: Quan F-S; Kim Y; Lee S; Yi H; Kang S-M; Bozja J; Moore ML; Compans RW
• Differential pathogenesis of respiratory syncytial virus clinical isolates in BALB/c mice.
  J Virol Volume: 85 Page(s): 5782 - 5793
  06/01/2011 Authors: Stokes KL; Chi MH; Sakamoto K; Newcomb DC; Currier MG; Huckabee MM; Lee S; Goleniewska K; Pretto C; Williams JV
• Genome-wide detection of a TFIID localization element from an initial human disease mutation.
  Nucleic Acids Res Volume: 39 Page(s): 2175 - 2187
  03/01/2011 Authors: Yang MQ; Laflamme K; Gotea V; Joiner CH; Seidel NE; Wong C; Petrykowska HM; Lichtenberg J; Lee S; Welch L
• Optimized combination therapy using bortezomib, TRAIL and TLR agonists in established breast tumors.
  Cancer Immunol Immunother Volume: 59 Page(s): 1073 - 1081
  07/01/2010 Authors: Lee S; Yagita H; Sayers TJ; Celis E
• Caffeine-mediated inhibition of calcium release channel inositol 1,4,5-trisphosphate receptor subtype 3 blocks glioblastoma invasion and extends survival.
  Cancer Res Volume: 70 Page(s): 1173 - 1183
  02/01/2010 Authors: Kang SS; Han K-S; Ku BM; Lee YK; Hong J; Shin HY; Almonte AG; Woo DH; Brat DJ; Hwang EM
• Enhancement of the CD8+ T cell response to a subdominant epitope of respiratory syncytial virus by deletion of an immunodominant epitope.
  Vaccine Volume: 26 Page(s): 4775 - 4782
  09/02/2008 Authors: Mok H; Lee S; Wright DW; Crowe JE
• Venezuelan equine encephalitis virus replicon particles encoding respiratory syncytial virus surface glycoproteins induce protective mucosal responses in mice and cotton rats.
  J Virol Volume: 81 Page(s): 13710 - 13722
  12/01/2007 Authors: Mok H; Lee S; Utley TJ; Shepherd BE; Polosukhin VV; Collier ML; Davis NL; Johnston RE; Crowe JE
• Tissue-specific regulation of CD8+ T-lymphocyte immunodominance in respiratory syncytial virus infection.
  J Virol Volume: 81 Page(s): 2349 - 2358
  03/01/2007 Authors: Lee S; Miller SA; Wright DW; Rock MT; Crowe JE
• Application of FGF-2 to modulate herpetic stromal keratitis.
  Curr Eye Res Volume: 31 Page(s): 1021 - 1028
  12/01/2006 Authors: Kim B; Lee S; Kaistha SD; Rouse BT
• Depletion of MCP-1 increases development of herpetic stromal keratitis by innate immune modulation.
  J Leukoc Biol Volume: 80 Page(s): 1405 - 1415
  12/01/2006 Authors: Kim B; Sarangi PP; Lee Y; Deshpande Kaistha S; Lee S; Rouse BT
• Vascular endothelial growth factor receptor 2-based DNA immunization delays development of herpetic stromal keratitis by antiangiogenic effects.
  J Immunol Volume: 177 Page(s): 4122 - 4131
  09/15/2006 Authors: Kim B; Suvas S; Sarangi PP; Lee S; Reisfeld RA; Rouse BT
• Application of plasmid DNA encoding IL-18 diminishes development of herpetic stromal keratitis by antiangiogenic effects.
  J Immunol Volume: 175 Page(s): 509 - 516
  07/01/2005 Authors: Kim B; Lee S; Suvas S; Rouse BT
• CXCR2-/- mice show enhanced susceptibility to herpetic stromal keratitis: a role for IL-6-induced neovascularization.
  J Immunol Volume: 172 Page(s): 1237 - 1245
  01/15/2004 Authors: Banerjee K; Biswas PS; Kim B; Lee S; Rouse BT
• CD4+CD25+ T cells regulate virus-specific primary and memory CD8+ T cell responses.
  J Exp Med Volume: 198 Page(s): 889 - 901
  09/15/2003 Authors: Suvas S; Kumaraguru U; Pack CD; Lee S; Rouse BT
• Influence of DNA encoding cytokines on systemic and mucosal immunity following genetic vaccination against herpes simplex virus.
  Microbes Infect Volume: 5 Page(s): 571 - 578
  06/01/2003 Authors: Lee S; Gierynska M; Eo SK; Kuklin N; Rouse BT
• Topical administration of plasmid-encoded monocyte chemoattractant protein-1 reduces severity of herpetic stromal keratitis by enhancing Th2 responses
  Volume: 17 Page(s): C20 - C20
  04/14/2003 Authors: Kim B; Lee S; Lee Y; Rouse BT
• Role of matrix metalloproteinase-9 in angiogenesis caused by ocular infection with herpes simplex virus.
  J Clin Invest Volume: 110 Page(s): 1105 - 1111
  10/01/2002 Authors: Lee S; Zheng M; Kim B; Rouse BT
• Induction of CD8 T-cell-specific systemic and mucosal immunity against herpes simplex virus with CpG-peptide complexes.
  J Virol Volume: 76 Page(s): 6568 - 6576
  07/01/2002 Authors: Gierynska M; Kumaraguru U; Eo S-K; Lee S; Krieg A; Rouse BT
• Mechanisms of pathogenesis in herpetic immunoinflammatory ocular lesions.
  Vet Microbiol Volume: 86 Page(s): 17 - 26
  04/22/2002 Authors: Deshpande SP; Zheng M; Lee S; Rouse BT
• On the role of MMP-9 in the HSK pathogenesis
  FASEB JOURNAL Volume: 16 Page(s): A1042 - A1042
  03/22/2002 Authors: Lee SJ; Zheng M; Rouse BT
• CD8+response induced by CpG-peptide may probably require CD4 help for maintenance.
  FASEB JOURNAL Volume: 16 Page(s): A680 - A680
  03/20/2002 Authors: Gierynska M; Kumaraguru U; Lee SJ; Rouse BT
• IL-12 suppresses the expression of ocular immunoinflammatory lesions by effects on angiogenesis.
  J Leukoc Biol Volume: 71 Page(s): 469 - 476
  03/01/2002 Authors: Lee S; Zheng M; Deshpande S; Eo SK; Hamilton TA; Rouse BT
• Contribution of vascular endothelial growth factor in the neovascularization process during the pathogenesis of herpetic stromal keratitis.
  J Virol Volume: 75 Page(s): 9828 - 9835
  10/01/2001 Authors: Zheng M; Deshpande S; Lee S; Ferrara N; Rouse BT
• Immunopotentiation of DNA vaccine against herpes simplex virus via co-delivery of plasmid DNA expressing CCR7 ligands.
  Vaccine Volume: 19 Page(s): 4685 - 4693
  09/14/2001 Authors: Eo SK; Lee S; Kumaraguru U; Rouse BT
• Bystander activation involving T lymphocytes in herpetic stromal keratitis.
  J Immunol Volume: 167 Page(s): 2902 - 2910
  09/01/2001 Authors: Deshpande S; Zheng M; Lee S; Banerjee K; Gangappa S; Kumaraguru U; Rouse BT
• Control of stromal keratitis by inhibition of neovascularization.
  Am J Pathol Volume: 159 Page(s): 1021 - 1029
  09/01/2001 Authors: Zheng M; Schwarz MA; Lee S; Kumaraguru U; Rouse BT
• Herpes simplex virus-induced keratitis: evaluation of the role of molecular mimicry in lesion pathogenesis.
  J Virol Volume: 75 Page(s): 3077 - 3088
  04/01/2001 Authors: Deshpande SP; Lee S; Zheng M; Song B; Knipe D; Kapp JA; Rouse BT
• Endothelial monocyte activating polypeptide II (EMAPII) suppresses angiogenesis and herpetic stromal keratitis.
  INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE Volume: 42 Page(s): S480 - S480
  03/15/2001 Authors: Zheng M; Schwarz MA; Deshpande S; Lee S; Torry DS; Rouse BT
• Plasmid vaccine expressing CCR7 ligands attract sufficient dendritic cells to abrogate impaired immunity at site of immune induction
  FASEB JOURNAL Volume: 15 Page(s): A1034 - A1034
  03/08/2001 Authors: Eo SK; Kumaraguru U; Lee S; Rouse BT
• Herpetic stromal keratitis: A possible autoimmune lesion but no involvement of molecular mimicry
  FASEB JOURNAL Volume: 15 Page(s): A1032 - A1032
  03/08/2001 Authors: Deshpande S; Zheng M; Lee S; Rouse BT
• Modulation of immunity against herpes simplex virus infection via mucosal genetic transfer of plasmid DNA encoding chemokines.
  J Virol Volume: 75 Page(s): 569 - 578
  01/01/2001 Authors: Eo SK; Lee S; Chun S; Rouse BT
• On the mechanisms of T cell silencing by IL-10 DNA: direct and indirect inhibition of T cell functions.
  Cell Immunol Volume: 206 Page(s): 59 - 69
  11/25/2000 Authors: Eo SK; Chun S; Lee S; Rouse BT
• Expression of IP-10 in the cornea controls the herpes virus induced immunoinflammatory ocular lesions
  JOURNAL OF LEUKOCYTE BIOLOGY Page(s): 26 - 26
  01/01/2000 Authors: Lee S; Eo SK; Chun S; Rouse BT
• Distribution fate and mechanism of immune modulation following mucosal delivery of plasmid DNA encoding IL-10.
  J Immunol Volume: 163 Page(s): 2393 - 2402
  09/01/1999 Authors: Chun S; Daheshia M; Lee S; Eo SK; Rouse BT
• Immune modulation by IL-10 gene transfer via viral vector and plasmid DNA: implication for gene therapy.
  Cell Immunol Volume: 194 Page(s): 194 - 204
  06/15/1999 Authors: Chun S; Daheshia M; Lee S; Rouse BT